# Clinical Validation of a Microfluidic Device for Isolation and Molecular Characterization of Circulating Tumor Cells

> **NCT01022723** · — · UNKNOWN · sponsor: **National Cancer Centre, Singapore** · enrollment: 817 (estimated)

## Conditions studied

- Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01022723
- **Lead sponsor:** National Cancer Centre, Singapore
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2009-10
- **Primary completion:** 2018-12
- **Final completion:** 2018-12
- **Target enrollment:** 817 (ESTIMATED)
- **Last updated:** 2018-09-14

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01022723

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01022723, "Clinical Validation of a Microfluidic Device for Isolation and Molecular Characterization of Circulating Tumor Cells". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01022723. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*